{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:15:49Z","timestamp":1793330149805,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Floyd and Mary Schwall Dissertation Year Fellowship in Medical Research"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM125012"],"award-info":[{"award-number":["R35GM125012"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.nano.2019.102067","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T11:47:17Z","timestamp":1563882437000},"page":"102067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Towards a nanoparticle-based prophylactic for maternal autoantibody-related autism"],"prefix":"10.1016","volume":"21","author":[{"given":"Amir","family":"Bolandparvaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rian","family":"Harriman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexi","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Edmiston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Navrotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vapniarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Van De Water","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2019.102067_bb0005","unstructured":"DSM-5 autism spectrum disorder fact sheet. Association AP. 2013."},{"issue":"3","key":"10.1016\/j.nano.2019.102067_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6503a1","article-title":"Prevalence and characteristics of autism Spectrum disorder among children aged 8 years\u2014autism and developmental disabilities monitoring network, 11 sites, United States, 2012","volume":"65","author":"Christensen","year":"2016","journal-title":"MMWR Surveill Summ"},{"issue":"12","key":"10.1016\/j.nano.2019.102067_bb0015","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1007\/s10803-015-2521-7","article-title":"Brief report: forecasting the economic burden of autism in 2015 and 2025 in the United States","volume":"45","author":"Leigh","year":"2015","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"10.1016\/j.nano.2019.102067_bb0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.64719\/pb.4346","article-title":"Treatment of autism spectrum disorder in children and adolescents","volume":"46","author":"DeFilippis","year":"2016","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"10.1016\/j.nano.2019.102067_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbi.2011.08.007","article-title":"The role of immune dysfunction in the pathophysiology of autism","volume":"26","author":"Onore","year":"2012","journal-title":"Brain Behav Immun"},{"issue":"2","key":"10.1016\/j.nano.2019.102067_bb0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41380-018-0099-0","article-title":"Maternal autoantibody related autism: mechanisms and pathways","volume":"24","author":"Jones","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"9","key":"10.1016\/j.nano.2019.102067_bb0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40263-015-0279-2","article-title":"Maternal anti-fetal brain IgG autoantibodies and autism spectrum disorder: current knowledge and its implications for potential therapeutics","volume":"29","author":"Fox-Edmiston","year":"2015","journal-title":"CNS Drugs"},{"issue":"23","key":"10.1016\/j.nano.2019.102067_bb0040","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1039\/C5CS00541H","article-title":"In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles","volume":"44","author":"Arami","year":"2015","journal-title":"Chem Soc Rev"},{"issue":"2","key":"10.1016\/j.nano.2019.102067_bb0045","first-page":"226","article-title":"Autism: maternally derived antibodies specific for fetal brain proteins","volume":"29","author":"Braunschweig","year":"2008","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.nano.2019.102067_bb0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"issue":"1\u20132","key":"10.1016\/j.nano.2019.102067_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2012.08.002","article-title":"Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model","volume":"252","author":"Braunschweig","year":"2012","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.nano.2019.102067_bb0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.03.011","article-title":"Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model","volume":"211","author":"Singer","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.nano.2019.102067_bb0065","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbi.2007.12.007","article-title":"Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism","volume":"22","author":"Martin","year":"2008","journal-title":"Brain Behav Immun"},{"issue":"8","key":"10.1016\/j.nano.2019.102067_bb0070","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"7\u20138","key":"10.1016\/j.nano.2019.102067_bb0075","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1369-7021(11)70163-8","article-title":"Magnetite nanoparticles for medical MR imaging","volume":"14","author":"Stephen","year":"2011","journal-title":"Mater Today (Kidlington)"},{"issue":"2","key":"10.1016\/j.nano.2019.102067_bb0080","doi-asserted-by":"crossref","DOI":"10.1088\/1468-6996\/16\/2\/023501","article-title":"Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications","volume":"16","author":"Wu","year":"2015","journal-title":"Sci Technol Adv Mater"},{"key":"10.1016\/j.nano.2019.102067_bb0085","doi-asserted-by":"crossref","first-page":"3476476","DOI":"10.1155\/2018\/3476476","article-title":"In vivo MRI of functionalized Iron oxide nanoparticles for brain inflammation","volume":"2018","author":"Tang","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"issue":"29","key":"10.1016\/j.nano.2019.102067_bb0090","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1016\/j.biomaterials.2011.06.026","article-title":"Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques","volume":"32","author":"Tu","year":"2011","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.nano.2019.102067_bb0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.rpor.2013.09.011","article-title":"Magnetic nanoparticle-based hyperthermia for cancer treatment","volume":"18","author":"Banobre-Lopez","year":"2013","journal-title":"Rep Pract Oncol Radiother"},{"issue":"8","key":"10.1016\/j.nano.2019.102067_bb0100","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/anie.200602866","article-title":"Magnetic nanoparticles: synthesis, protection, functionalization, and application","volume":"46","author":"Lu","year":"2007","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"10.1016\/j.nano.2019.102067_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajh.21656","article-title":"FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease","volume":"85","author":"Lu","year":"2010","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.nano.2019.102067_bb0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.etp.2015.07.005","article-title":"Investigating the cytotoxicity of iron oxide nanoparticles in in vivo and in vitro studies","volume":"67","author":"Ghasempour","year":"2015","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.nano.2019.102067_bb0115","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.2147\/IJN.S138108","article-title":"Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging","volume":"12","author":"Unterweger","year":"2017","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.nano.2019.102067_bb0120","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/s41598-018-19628-z","article-title":"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings","volume":"8","author":"Feng","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.nano.2019.102067_bb0125","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.actbio.2014.01.025","article-title":"Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications","volume":"10","author":"Kruse","year":"2014","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2019.102067_bb0130","article-title":"Mahcicek, Huseyin Sozeri, Ergin Atalar","volume":"39","author":"Selim Sulek","year":"2011","journal-title":"Ayse B. Tekinaya and Mustafa O. Guler. Peptide functionalized superparamagnetic iron oxide nanoparticles as MRI contrast agents"},{"key":"10.1016\/j.nano.2019.102067_bb0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbi.2017.12.014","article-title":"Identification of the antigenic epitopes of maternal autoantibodies in autism spectrum disorders","volume":"69","author":"Edmiston","year":"2018","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.nano.2019.102067_bb0140","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/18\/3\/035603","article-title":"Size-controlled synthesis of dextran sulfate coated iron oxide nanoparticles for magnetic resonance imaging","volume":"18","author":"Jarrett","year":"2007","journal-title":"Nanotechnology"},{"issue":"1","key":"10.1016\/j.nano.2019.102067_bb0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/1556-276X-8-423","article-title":"Magnetic properties of fluffy Fe@alpha-Fe2O3 core-shell nanowires","volume":"8","author":"Cao","year":"2013","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"10.1016\/j.nano.2019.102067_bb0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1109\/TNB.2003.820277","article-title":"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies","volume":"3","author":"Gupta","year":"2004","journal-title":"IEEE Trans Nanobioscience"},{"issue":"18","key":"10.1016\/j.nano.2019.102067_bb0155","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.biomaterials.2006.01.043","article-title":"The in-vitro bioactivity of mesoporous bioactive glasses","volume":"27","author":"Yan","year":"2006","journal-title":"Biomaterials"},{"issue":"29","key":"10.1016\/j.nano.2019.102067_bb0160","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.1600816113","article-title":"pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation","volume":"113","author":"Nuhn","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.nano.2019.102067_bb0170","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/nnm.11.19","article-title":"Nanoparticle PEGylation for imaging and therapy","volume":"6","author":"Jokerst","year":"2011","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2019.102067_bb0175","doi-asserted-by":"crossref","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99(Pt A):28\u201351.","DOI":"10.1016\/j.addr.2015.09.012"},{"issue":"17","key":"10.1016\/j.nano.2019.102067_bb0180","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1039\/C3TB21460E","article-title":"Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres","volume":"2","author":"Lewis","year":"2014","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2019.102067_bb0185","doi-asserted-by":"crossref","unstructured":"James S. Lowe. Stevens & Lowe's human histology (fourth edition), chapter 9 \u2014 blood and lymphatic circulatory systems and heart 2015.","DOI":"10.1016\/B978-0-7234-3502-0.00009-7"},{"key":"10.1016\/j.nano.2019.102067_bb0190","first-page":"7","article-title":"Effect of concentrated ambient particulate matter on blood coagulation parameters in rats","volume":"111","author":"Nadziejko","year":"2002","journal-title":"Res Rep Health Eff Inst"},{"issue":"4","key":"10.1016\/j.nano.2019.102067_bb0195","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today."},{"key":"10.1016\/j.nano.2019.102067_bb0200","doi-asserted-by":"crossref","unstructured":"C. Branca SM, G. Maisano, F. Migliardo, P. Migliardo, G. Romeo. Hydration study of PEG\/water mixtures by quasi elastic light scattering, acoustic and rheological measurements. J Phys Chem B 2002;106(2002):10272\u20136.","DOI":"10.1021\/jp014345v"},{"issue":"37","key":"10.1016\/j.nano.2019.102067_bb0205","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.1412420111","article-title":"Clearance of pathological antibodies using biomimetic nanoparticles","volume":"111","author":"Copp","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.nano.2019.102067_bb0210","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s11095-010-0260-1","article-title":"PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications","volume":"27","author":"Yallapu","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2019.102067_bb0215","unstructured":"Kang KGNaET. Functionalization of inorganic nanoparticles with polymers for stealth biomedical applications. Polymer Chemistry 2010."},{"issue":"11","key":"10.1016\/j.nano.2019.102067_bb0220","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.nano.2019.102067_bb0225","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.colsurfb.2014.04.027","article-title":"Effect of PEG molecular weight on stability, T(2) contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs)","volume":"119","author":"Park","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"10.1016\/j.nano.2019.102067_bb0230","first-page":"919","article-title":"Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum","volume":"11","author":"Semenova","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.nano.2019.102067_bb0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mcp.2012.01.002","article-title":"Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals","volume":"26","author":"Dauner","year":"2012","journal-title":"Mol Cell Probes"},{"issue":"10","key":"10.1016\/j.nano.2019.102067_bb0240","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1021\/acs.jcim.6b00215","article-title":"Characterization, in vivo evaluation, and molecular modeling of different propofol-cyclodextrin complexes to assess their drug delivery potential at the blood-brain barrier level","volume":"56","author":"Shityakov","year":"2016","journal-title":"J Chem Inf Model"},{"issue":"27","key":"10.1016\/j.nano.2019.102067_bb0245","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2019.102067_bb0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jtemb.2016.03.017","article-title":"Are iron oxide nanoparticles safe? Current knowledge and future perspectives","volume":"38","author":"Valdiglesias","year":"2016","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.nano.2019.102067_bb0255","doi-asserted-by":"crossref","unstructured":"Masoud Rezaei HM, Karim Khoshgard, Alireza Montazerabadi, Ahmad, Mohammadbeigi FO. The cytotoxicity of dextran-coated iron oxide nanoparticles on Hela and MCF-7 cancerous cell lines. Iranian Journal of Toxicology 2017;11(5):31\u20136.","DOI":"10.29252\/arakmu.11.5.31"},{"key":"10.1016\/j.nano.2019.102067_bb0260","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2147\/IJN.S13244","article-title":"Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress","volume":"5","author":"Naqvi","year":"2010","journal-title":"Int J Nanomedicine"},{"issue":"12","key":"10.1016\/j.nano.2019.102067_bb0265","doi-asserted-by":"crossref","first-page":"30251","DOI":"10.3390\/ijms161226231","article-title":"Short- and long-term effects of prenatal exposure to iron oxide nanoparticles: influence of surface charge and dose on developmental and reproductive toxicity","volume":"16","author":"Di Bona","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.nano.2019.102067_bb0270","first-page":"1221","article-title":"Mehrdad Modaresi, Manoochehr Messripour, Mohamad Hasan Yousefi and Gholam Reza Amiri. Effect of magnetic iron oxide nanoparticles on pregnancy and testicular development of mice","volume":"10","author":"Ali Noori","year":"2011","journal-title":"Afr J Biotechnol"},{"issue":"5","key":"10.1016\/j.nano.2019.102067_bb0275","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.3390\/ijms13055554","article-title":"Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture","volume":"13","author":"Yu","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.nano.2019.102067_bb0280","doi-asserted-by":"crossref","first-page":"24417","DOI":"10.3390\/ijms161024417","article-title":"In vitro\/in vivo toxicity evaluation and quantification of iron oxide nanoparticles","volume":"16","author":"Patil","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.nano.2019.102067_bb0285","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20101825","article-title":"Regulation of cellular iron metabolism","volume":"434","author":"Wang","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.nano.2019.102067_bb0290","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.2147\/IJN.S136453","article-title":"Iron oxide nanoparticles induce cytokine secretion in a complement-dependent manner in a human whole blood model","volume":"12","author":"Wolf-Grosse","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2019.102067_bb0295","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fimmu.2016.00418","article-title":"Activation of human complement system by dextran-coated iron oxide nanoparticles is not affected by dextran\/Fe ratio, hydroxyl modifications, and crosslinking","volume":"7","author":"Wang","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2019.102067_bb0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12989-014-0064-2","article-title":"Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum","volume":"11","author":"Banda","year":"2014","journal-title":"Part Fibre Toxicol"},{"key":"10.1016\/j.nano.2019.102067_bb0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nantod.2017.03.001","article-title":"Complement activation turnover on surfaces of nanoparticles","volume":"15","author":"Moghimi","year":"2017","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2019.102067_bb0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-2094-4-13","article-title":"Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice","volume":"4","author":"Leinhase","year":"2007","journal-title":"J Neuroinflammation"},{"issue":"8","key":"10.1016\/j.nano.2019.102067_bb0315","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.nano.2013.05.010","article-title":"A comprehensive analysis of transfection-assisted delivery of iron oxide nanoparticles to dendritic cells","volume":"9","author":"Toki","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2019.102067_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2018.1489192","article-title":"Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant","author":"Neto LMM ZN","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.nano.2019.102067_bb0325","doi-asserted-by":"crossref","unstructured":"Judy Van de Water KLJ, Jill Silverman, Mu Yang, Jacqueline Crawley. Autism-specific maternal autoantibodies produce ASD relevant behaviors in a mouse model. Biol Psychiatry 2018;83(9):S147-S8.","DOI":"10.1016\/j.biopsych.2018.02.385"},{"issue":"2","key":"10.1016\/j.nano.2019.102067_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2131\/jts.41.175","article-title":"Evaluation of the potential toxicity of unmodified and modified cyclodextrins on murine blood-brain barrier endothelial cells","volume":"41","author":"Shityakov","year":"2016","journal-title":"J Toxicol Sci"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419301510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419301510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:10:14Z","timestamp":1761549014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963419301510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":65,"alternative-id":["S1549963419301510"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2019.102067","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards a nanoparticle-based prophylactic for maternal autoantibody-related autism","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2019.102067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102067"}}